Generalized Convulsive Status Epilepticus in Adults and Children: Treatment Guidelines and Protocols

Emergency Medicine Clinics of North America

Volumn 29, Issue 1, 2011, Pages 51-64

  Shearer, Peter ^a,b   Riviello, James ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Benzodiazepines; Electroencephalography; Generalized convulsive status epilepticus; Non convulsive status epilepticus; Refractory status epilepticus; Status epilepticus

Indexed keywords

BENZODIAZEPINE; CEFTRIAXONE; DIAZEPAM; DOBUTAMINE; FOSPHENYTOIN SODIUM; GLUCOSE; LORAZEPAM; MIDAZOLAM; NORADRENALIN; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PLACEBO; PROPOFOL; THIAMINE; THIOPENTAL; VALPROIC ACID; VANCOMYCIN;

ADULT; ALGORITHM; ANTICONVULSANT THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG HALF LIFE; DRUG INFUSION; DRUG MEGADOSE; DRUG METABOLISM; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; GENERALIZED CONVULSIVE STATUS EPILEPTICUS; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPOTENSION; LABORATORY TEST; LOADING DRUG DOSE; LUMBAR PUNCTURE; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; NERVOUS SYSTEM INJURY; NEUROIMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; SYSTEMIC DISEASE;

EID: 78649427242     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2010.08.005     Document Type: Review

References (60)

1. DeLorenzo R.J., Hauser W.A., Towne A.R., et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46(4):1029-1035.
2. Working Group on Status Epilepticus Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993, 270:854-859. [see comments].
3. Lowenstein D.H., Bleck T., Macdonald R.L. It's time to revise the definition of status epilepticus. Epilepsia 1999, 40(1):120-122.
4. Alldredge B.K., Gelb A.M., Isaacs S.M., et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001, 345(9):631-637.
5. Treiman D.M., Meyers P.D., Walton N.Y., et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339(12):792-798.
6. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology 1990, 40(5 Suppl 2):13-23.
7. Delanty N., French J.A., Labar D.R., et al. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure 2001, 10(2):116-119.
8. Coeytaux A., Jallon P., Galobardes B., et al. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000, 55(5):693-697.
9. Knake S., Rosenow F., Vescovi M., et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001, 42(6):714-718.
10. Vignatelli L., Tonon C., D'Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 2003, 44(7):964-968.
11. Wu Y.W., Shek D.W., Garcia P.A., et al. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002, 58(7):1070-1076.
12. Shinnar S., Pellock J.M., Moshe S.L., et al. In whom does status epilepticus occur: age-related differences in children. Epilepsia 1997, 38(8):907-914.
13. Sillanpaa M., Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol 2002, 52(3):303-310.
14. Logroscino G., Hesdorffer D.C., Cascino G.D., et al. Long-term mortality after a first episode of status epilepticus. Neurology 2002, 58(4):537-541.
15. DeLorenzo R.J., Towne A.R., Pellock J.M., et al. Status epilepticus in children, adults, and the elderly. Epilepsia 1992, 33(Suppl 4):S15-S25.
16. Maytal J., Shinnar S., Moshe S.L., et al. Low morbidity and mortality of status epilepticus in children. Pediatrics 1989, 83(3):323-331.
17. Bui T.T., Delgado C.A., Simon H.K. Infant seizures not so infantile: first-time seizures in children under six months of age presenting to the ED. Am J Emerg Med 2002, 20(6):518-520.
18. Lowenstein D.H., Alldredge B.K. Status epilepticus. N Engl J Med 1998, 338(14):970-976.
19. Jagoda A., Riggio S. Refractory status epilepticus in adults. Ann Emerg Med 1993, 22(8):1337-1348.
20. Walton N.Y., Treiman D.M. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp Neurol 1988, 101(2):267-275.
21. Lowenstein D.H., Alldredge B.K. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993, 43(3 Pt 1):483-488.
22. Meldrum B.S., Vigouroux R.A., Brierley J.B. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 1973, 29(2):82-87.
23. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995, 345(8963):1455-1463.
24. Aminoff M.J., Simon R.P. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 1980, 69(5):657-666.
25. Quigg M., Shneker B., Domer P. Current practice in administration and clinical criteria of emergent EEG. J Clin Neurophysiol 2001, 18(2):162-165.
26. DeLorenzo R.J., Waterhouse E.J., Towne A.R., et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39(8):833-840.
27. Shepherd S.M. Management of status epilepticus. Emerg Med Clin North Am 1994, 12:941-961.
28. Appleton R., Choonara I., Martland T., et al. The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party. Arch Dis Child 2000, 83(5):415-419.
29. Walker M.C., Smith S.J., Shorvon S.D. The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia 1995, 50(2):130-135.
30. Garr R.E., Appleton R.E., Robson W.J., et al. Children presenting with convulsions (including status epilepticus) to a paediatric accident and emergency department: an audit of a treatment protocol. Dev Med Child Neurol 1999, 41(1):44-47.
31. Leppik I.E., Derivan A.T., Homan R.W., et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983, 249(11):1452-1454.
32. Chin R.F.M., Neville B.G.R., Peckham C., et al. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol 2008, 7:696-703.
33. Appleton R., Sweeney A., Choonara I., et al. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 1995, 37(8):682-688.
34. Chamberlain J.M., Altieri M.A., Futterman C., et al. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 1997, 13(2):92-94.
35. Towne A.R., DeLorenzo R.J. Use of intramuscular midazolam for status epilepticus. J Emerg Med 1999, 17(2):323-328.
36. Browne T.R. The pharmacokinetics of agents used to treat status epilepticus. Neurology 1990, 40(5 Suppl 2):28-32.
37. Manno E.M. New management strategies in the treatment of status epilepticus. Mayo Clin Proc 2003, 78(4):508-518.
38. Kilarski D.J., Buchanan C., Von Behren L. Soft-tissue damage associated with intravenous phenytoin. N Engl J Med 1984, 311(18):1186-1187.
39. O'Brien T.J., Cascino G.D., So E.L., et al. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology 1998, 51(4):1034-1039.
40. Burneo J.G., Anandan J.V., Barkley G.L. A prospective study of the incidence of the purple glove syndrome. Epilepsia 2001, 42(9):1156-1159.
41. Rosenow F., Arzimanoglou A., Baulac M. Recent developments in treatment of status epilepticus: a review. Epileptic Disord 2002, 4(Suppl 2):S41-S51.
42. Browne T.R., Kugler A.R., Eldon M.A. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996, 46(6 Suppl 1):S3-S7.
43. Fischer J.H., Patel T.V., Fischer P.A. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet 2003, 42(1):33-58.
44. Devinsky O., Leppik I., Willmore L.J., et al. Safety of intravenous valproate. Ann Neurol 1995, 38(4):670-674.
45. Giroud M., Gras D., Escousse A., et al. Use of injectable valproic acid in status epilepticus. Drug Investigation 1993, 5(3):154-159.
46. Hovinga C.A., Chicella M.F., Rose D.F., et al. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother 1999, 33(5):579-584.
47. Venkataraman V., Wheless J.W. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999, 35(2):147-153.
48. Shaner D.M., McCurdy S.A., Herring M.O., et al. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988, 38(2):202-207.
49. Walker I.A., Slovis C.M. Lidocaine in the treatment of status epilepticus. Acad Emerg Med 1997, 4(9):918-922.
50. Pascual J., Sedano M.J., Polo J.M., et al. Intravenous lidocaine for status epilepticus. Epilepsia 1988, 29(5):584-589.
51. Lampl Y., Eshel Y., Gilad R., et al. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990, 19(6):674-676.
52. Yeoman P., Hutchinson A., Byrne A., et al. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med 1989, 15(4):255-259.
53. Kumar A., Bleck T.P. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992, 20(4):483-488.
54. Claassen J., Hirsch L.J., Emerson R.G., et al. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43(2):146-153.
55. Prasad A., Worrall B.B., Bertram E.H., et al. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001, 42(3):380-386.
56. Brown L.A., Levin G.M. Role of propofol in refractory status epilepticus. Ann Pharmacother 1998, 32(10):1053-1059.
57. Cannon M.L., Glazier S.S., Bauman L.A. Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion. J Neurosurg 2001, 95(6):1053-1056.
58. Bray R.J. Propofol infusion syndrome in children. Paediatr Anaesth 1998, 8(6):491-499.
59. Makela J.P., Iivanainen M., Pieninkeroinen I.P., et al. Seizures associated with propofol anesthesia. Epilepsia 1993, 34(5):832-835.
60. Parviainen I., Uusaro A., Kalviainen R., et al. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002, 59(8):1249-1251.